Methods and analysis
hematologic malignant diseases
BLOOD, APLASTIC ANEMIA
Study participants were identified from the Blood or Marrow Transplant Survivor Study (BMTSS), which is a retrospective cohort study of patients who received HCT at City of Hope (COH), University of Minnesota, or University of Alabama at Birmingham (UAB) for hematologic malignant diseases, or severe aplastic anemia, and survived at least 2 years after HCT [